Paperonium

Diabetes · Nat Metab · 2024

The summary says the tested pancreas cells came from diabetic people. Only the added blood did.

Cell donors given serumThe summaryall had type 2 diabetesIts own donor table0 of 11 had type 2 diabetesBlood donors, who exercised5 of 5 had type 2 diabetes
Cell donors given serumThe summaryall had type 2 diabetesIts own donor table0 of 11 had type 2 diabetesBlood donors, who exercised5 of 5 had type 2 diabetes

Who had type 2 diabetes: the cell donors or the blood donors

The paper says

The summary’s only human-cell result: insulin-making pancreas cells, bathed in serum (the liquid part of blood) collected after a 10-week exercise programme, showed fewer signs of worn-out, ageing cells. It says the cell donors, the people those cells came from, had type 2 diabetes.

Its own data show

The paper’s own table of cell donors (people whose pancreases were donated after death) marks every one as not having type 2 diabetes, including all 11 whose cells got serum. The people with diabetes were the blood donors: its results say the serum came from five exercisers with type 2 diabetes.

A lab test speaks only for the cells it used. The paper argues exercise could reduce worn-out insulin-making cells in people who already have diabetes, but it reports no test on their cells: it put diabetic exercisers’ serum on cells from people without diabetes. The measurements stand; the summary misstates whose cells they were.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence · Nat Metab (2024) · doi:10.1038/s42255-024-01130-8